VTE and Obesity
 |
The Challenges at the Intersection of VTE and Obesity: Defining the Issues CME, CNE, CE Rachel P. Rosovsky, MD, MPH; Stephan Moll, MD; and Bishoy Ragheb, PharmD, BCACP, CDE, CACP, CTTS |
|
| Release Date: February 14, 2024 Expiration Date: February 14, 2025 |
||
|
This activity, the first in a two-part series, focuses on the effects of obesity on VTE and anticoagulation therapy. Follow along with the faculty as they clarify the relationship between obesity and VTE and outline strategies for tailoring anticoagulation therapy based on body mass index (BMI) and other relevant factors. A case study is included to help demonstrate the challenges of – and solutions to – anticoagulation therapy in this patient population. Provided by MediCom Worldwide, Inc.This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc. administered by Janssen Scientific Affairs, LLC. |
||
| Begin, Earn CreditView Only, No Credit | ||
 |
Anticoagulation in Obese Patients: Applied Clinical Practices in the Non-specialist Setting CME, CNE, CE Rachel P. Rosovsky, MD, MPH; Stephan Moll, MD; and Bishoy Ragheb, PharmD, BCACP, CDE, CACP, CTTS |
|
| Release Date: February 14, 2024 Expiration Date: February 14, 2025 |
||
|
This activity, the second in a two-part series, explores anticoagulation treatment strategies in special patient groups, including patients with heavy menses, renal issues, or a history of bariatric surgery. This activity is designed to equip its participants with strategies for ensuring optimal anticoagulation in a variety of situations in patients both with and without obesity. Provided by MediCom Worldwide, Inc.This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc. administered by Janssen Scientific Affairs, LLC. |
||
| Begin, Earn CreditView Only, No Credit | ||